Vinorelbine (Navelbiner`): A Third-Generation Vinca Alkaloid
- 1 January 1997
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 15 (5) , 475-490
- https://doi.org/10.3109/07357909709047587
Abstract
The vinca alkaloids represent one of the oldest classes of antineoplastic agents used in humans with a wide spectrum of activity against both animal and human tumors. These agents are known to inhibit microtubule polymerization. Vinorelbine is a semisynthetic analog that reached Clinical Trial on the basis of less preclinical evidence of toxicity to neuronal tissue and greater cytotoxic activity in preclinical models than the older compounds of this class. In humans, the clearance of this agent shows a wide variation among subjects with the predominant toxicity being hematological. Significant antitumor activity has been observed in diseases that previously have been shown to respond to vinca alkaloids.Keywords
This publication has 33 references indexed in Scilit:
- A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neckEuropean Journal Of Cancer, 1993
- Digital cell image analysis of verapamil-induced effects in chemosensitive and chemoresistant neoplastic cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patientsEuropean Journal Of Cancer, 1993
- Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Phase I–II study of vinorelbine (Navelbine®) plus cisplatin in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1992
- The Current and Future Place of Vinorelbine in Cancer TherapyDrugs, 1992
- A Review of the Antitumour Activity of Vinorelbine in Breast CancerDrugs, 1992
- Oral administration of [3H]navelbine in patientsAnti-Cancer Drugs, 1991
- Phase II study of navelbine in advanced renal cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Generation and Characterization of a Low-Degree Drug-Resistant Human Tumor Cell LineOncology, 1990